Unraveling Vulnerabilities in Endocrine Therapy-Resistant HER2+/ER + Breast Cancer.
Shaymaa BahnassyHillary S AndrewsLu JinStanley TamDua MobinManasi BalachandranMircea PodarMatthew D McCoyRobert A BeckmanRebecca B RigginsPublished in: Endocrinology (2023)
The BT474 and MM361 AI-resistant models capture distinct phenotypes of HER2+/ER + BCa and identify altered lipid metabolism and ferroptosis remodeling as vulnerabilities of this type of ETR BCa.